trypan blue has been researched along with paclitaxel in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bernacki, RJ; Brattain, MG; Li, F; Ling, X | 1 |
| Georgatos, SD; Georgoulias, V; Koutala, H; Michalakis, J; Romanos, J; Theodoropoulos, PA; Tsiftsis, D | 1 |
| Chan, WK; Roubin, RH; Sekhon, BK; Sze, DM; Tan, A | 1 |
| Ding, J; Hu, M; Lou, B; Qu, F; Zhang, L | 1 |
| Guo, H; Jiang, L; Liu, H; Ma, J; Xu, Y; Yang, H; Yu, G; Yuan, C; Zhang, Y | 1 |
| Kammerer, S; Küpper, JH; Nowak, E | 1 |
7 other study(ies) available for trypan blue and paclitaxel
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Induction of survivin expression by taxol (paclitaxel) is an early event, which is independent of taxol-mediated G2/M arrest.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Base Sequence; Blotting, Western; Cell Death; Cell Line, Tumor; Cell Survival; Coloring Agents; Cyclin B; Cyclin B1; DNA; Dose-Response Relationship, Drug; Flow Cytometry; G2 Phase; Humans; Inhibitor of Apoptosis Proteins; Luciferases; MAP Kinase Kinase Kinase 1; MAP Kinase Kinase Kinases; Microscopy, Fluorescence; Microtubule-Associated Proteins; Mitosis; Molecular Sequence Data; Neoplasm Proteins; Paclitaxel; Phosphatidylinositol 3-Kinases; Phosphorylation; Propidium; RNA, Small Interfering; Survivin; Time Factors; Transfection; Trypan Blue; Up-Regulation | 2004 |
Micromolar taxol, with or without hyperthermia, induces mitotic catastrophe and cell necrosis in HeLa cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flow Cytometry; HeLa Cells; Hot Temperature; Humans; In Situ Nick-End Labeling; Mitosis; Mitotic Index; Necrosis; Paclitaxel; Trypan Blue | 2005 |
High-throughput screening platform for anticancer therapeutic drug cytotoxicity.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Separation; Cell Survival; Colorimetry; Coloring Agents; Drug Screening Assays, Antitumor; Humans; Indicators and Reagents; Monocytes; Multiple Myeloma; Paclitaxel; Propolis; Reproducibility of Results; Tetrazolium Salts; Thiazoles; Trypan Blue | 2008 |
Capillary zone electrophoresis-based cytotoxicity analysis of Caco-2 cells.
Topics: Caco-2 Cells; Cadmium Chloride; Cell Membrane; Cell Survival; Electrophoresis, Capillary; Humans; Linear Models; Methylmercury Compounds; Paclitaxel; Sulfites; Toxicity Tests; Trypan Blue | 2012 |
Silencing prion protein in MDA-MB-435 breast cancer cells leads to pleiotropic cellular responses to cytotoxic stimuli.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Doxorubicin; Drug Resistance, Neoplasm; Extracellular Signal-Regulated MAP Kinases; Gene Silencing; Genes, p53; Humans; Paclitaxel; Plasmids; Prions; Retroviridae; RNA, Small Interfering; Signal Transduction; Staurosporine; Trypan Blue | 2012 |
ATP-based cell viability assay is superior to trypan blue exclusion and XTT assay in measuring cytotoxicity of anticancer drugs Taxol and Imatinib, and proteasome inhibitor MG-132 on human hepatoma cell line HepG2.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Biological Assay; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Humans; Imatinib Mesylate; Liver Neoplasms; Paclitaxel; Proteasome Inhibitors; Trypan Blue | 2018 |